News

XcelABLE and Oculogica® Partner to include EyeBOX® Concussion Diagnostics in Medical Evaluations

XcelABLE and Oculogica® Partner to include EyeBOX® Concussion Diagnostics in Medical Evaluations

XcelABLE, a global provider of Functional Capacity Evaluations (FCEs) and Independent Medical Examinations (IMEs), has partnered with Oculogica, developer of the EyeBOX concussion test. EyeBOX has the most FDA clearances of any concussion test, and is the subject of multiple peer-reviewed publications. It was the first concussion test cleared by FDA for use without a […]

XcelABLE and Oculogica® Partner to include EyeBOX® Concussion Diagnostics in Medical Evaluations Read More »

Royal Spine Surgery Clinic in Arizona Acquires New Technology to Better Assess Concussion

Scottsdale, AZ –06/05/2025- Royal Spine Surgery in Scottsdale, AZ is the latest clinic in Arizona to offer a new test to diagnose concussion, EyeBOX® manufactured by the Wisconsin based company, Oculogica. The test is based on eye-tracking technology and is the first FDA approved test for concussion that does not require a pre-injury baseline test.

Royal Spine Surgery Clinic in Arizona Acquires New Technology to Better Assess Concussion Read More »

Ontario Researchers to Pioneer New Concussion Diagnostic Tool in Canada

The TRANSCENDENT Concussion Research Program, led by Ontario-based researchers, is the first and only site in Canada to offer the newest test for concussion, EyeBOX®. TRANSCENDENT is a research collaboration funded by the Ontario Brain Institute and supported by the CHEO (Children’s Hospital of Eastern Ontario) Research Institute and 360 Concussion Care, a multi-specialty concussion

Ontario Researchers to Pioneer New Concussion Diagnostic Tool in Canada Read More »

FDA approves broadest label in the industry for Oculogica’s EyeBOX®  Concussion Diagnostic

Oculogica Inc., a pioneer in the development of non-invasive, objective diagnostic tools for brain injuries, is proud to announce that the U.S. Food and Drug Administration (FDA) has granted an expanded label for its groundbreaking EyeBOX® technology. The updated label permits clinicians to compare a patient with an injury against a normative population, allowing physicians

FDA approves broadest label in the industry for Oculogica’s EyeBOX®  Concussion Diagnostic Read More »

EyeBOX Receives Health Canada Approval for Concussion Diagnosis Technology

Oculogica is proud to announce that Health Canada has approved the EyeBOX concussion diagnostic, an innovative device designed to assist healthcare providers in the diagnosis of concussions. This regulatory approval marks a major milestone for EyeBOX, which will now be available to healthcare professionals throughout Canada to help quickly and accurately assess mild traumatic brain

EyeBOX Receives Health Canada Approval for Concussion Diagnosis Technology Read More »

jack king publication press release

Oculogica’s EyeBOX shines in new study published in Military Medicine

August 20, 2024, New Richmond, WI Oculogica Inc. is pleased to highlight a publication this week by a Department ofDefense based research team on the company’s EyeBOX concussion diagnostictechnology. The study, Comparative Performance of Three Eye-Tracking Devices inDetection of Mild Traumatic Brain Injury in Acute Versus Chronic Subject Populations,was published in Military Medicine on August 17,

Oculogica’s EyeBOX shines in new study published in Military Medicine Read More »

Jody Hayes

Oculogica Welcomes Jody Hayes as Director of Market Access and Reimbursement

We are thrilled to share some exciting news with you today as we welcome a newmember to the Oculogica team. Jody Hayes, an industry veteran with 15 years ofexpertise in medical device market access and reimbursement, is joining us as the newDirector of Market Access and Reimbursement. Jody brings a wealth of knowledge anda passion

Oculogica Welcomes Jody Hayes as Director of Market Access and Reimbursement Read More »

Scroll to Top